Friday, November 13, 2026
News

AI equipped OS-SiA digital pathology scanner developed by OptraSCAN granted US patent

SocialTwist Tell-a-Friend    Print this Page   COMMENT

Business | May 30, 2022 3:24:56 PM IST
Pune (Maharashtra) [India], May 30 (ANI/NewsVoir): OptraSCAN, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned image along with analyzed output as an overlay during their review process.

The patent describes a technique invented by OptraSCAN, the AI-enabled digital pathology scanner OS-SiA automatically identifies specimens to scan and simultaneously analyses the tissue or cell area being scanned. OS-SiA is the industry's first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights.

"Currently, the digital pathology slide scanners are restricted to partial or whole slide image acquisition and digitization into an image. Our next-generation scanner OS-SiA scans and analyses simultaneously eliminating the need for additional processing applications," said Abhi Gholap, Founder & CEO, OptraSCAN. "This patent highlights our constant efforts to improve the adoption of digital pathology solutions and support the pathology community."

OS-SiA can be embedded in the existing series of its cloud-enabled brightfield scanners namely OS-Lite and OS-Ultra. The custom algorithms provide real-time ROI detection while scanning, cell quantification for IHC/HNE markers, morphological measurements built using the core library. The whole slide image can be viewed in a local/web-based/cloud-based image viewer. The deep learning computational module is provided for self-learning in the scanning device.

"This is the kind of breakthrough we need to accelerate the adoption of digital pathology, simultaneous scanning and analysis will help pathologists make faster decisions and improve patient outcomes," Dr. Zu-Hua Gao MD, Medical Advisor at OptraSCAN and Chair - Pathology, University of British Columbia

OptraSCAN are pioneers in the On-Demand Digital Pathology System, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the barriers to "Go Digital" no matter the size of the pathology lab, the lab's throughput, or global location.

OptraSCAN's end-to-end digital pathology solution provides effective acquisition of whole slide images, viewing, storing, real-time sharing, reporting and AI & ML based Image analysis solutions via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
NSEIX opens European markets to Indian i...
India-Africa Food Security, Agri Trade &...
OMCs' losses narrow as crude cools, but ...
Last Chance to Apply: SIIB Admissions Cl...
Bodhi Tree acquires majority stake in So...
India's industrial equipment sector like...
More...
 
INDIA WORLD ASIA
PM Modi inaugurates Namma Metro Pink Lin...
IMD forecasts snowfall in Himachals hig...
'Zero tolerance against terrorism': HM A...
'Want to show nation, who's anti-nationa...
PM Modi inaugurates new Vande Bharat cha...
'Congress has deep roots in Uttar Prades...
More...    
 
 Top Stories
India vs New Zealand T20I Series 20... 
SSBeauty by Shoppers Stop Presents ... 
Nurture Well Industries Ltd Reports... 
Sensex falls 319 points, Nifty drop... 
BJP leader Nalin Kohli accuses Rahu... 
Congress leadership discusses futur... 
SIGILUM Strengthens Platform Securi... 
Scotch whisky import dispute likely...